Tumor mutational load predicts survival after immunotherapy across multiple cancer types
2019 · Nature Genetics · 4,300 citations
https://doi.org/10.1038/s41588-018-0312-8
R
Rona Yaeger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
876
Papers
35.0K
Citations
74
h-index
170
i10-index
Rona Yaeger is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 74, co-authored 745 publications.
ORCID: 0000-0002-7233-5454Papers by this author
worksMutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
2017 · Nature Medicine · 3,415 citations
https://doi.org/10.1038/nm.4333
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
2022 · Journal of Clinical Oncology · 843 citations
https://doi.org/10.1200/jco.22.00032
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated <i>BRAF</i> V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
2021 · Journal of Clinical Oncology · 503 citations
https://doi.org/10.1200/jco.20.02088
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
2020 · Cancer Discovery · 443 citations
https://doi.org/10.1158/2159-8290.cd-20-0187
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C
2022 · New England Journal of Medicine · 440 citations
https://doi.org/10.1056/nejmoa2212419
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat